Objective-Clinical and experimental studies demonstrate the important roles of vascular smooth muscle cells (VSMC) in the pathogenesis of atherosclerosis. We have previously determined that the osteogenic transcription factor Runx2 is essential for VSMC calcification. The present study characterized Runx2-regulated signals and their potential roles in vascular calcification. Methods and Results-In vivo studies with atherogenic apolipoprotein E Ϫ/Ϫ mice demonstrated that increased oxidative stress was associated with upregulation of Runx2 and receptor activator of nuclear factor B ligand (RANKL), which colocalized in the calcified atherosclerotic lesions and were juxtaposed to infiltrated macrophages and osteoclast-like cells that are positively stained for an osteoclast marker, tartrate-resistant acid phosphatase. Mechanistic studies using RNA interference, a luciferase reporter system, chromatin immunoprecipitation, and electrophoretic mobility shift assays indicated that Runx2 regulated the expression of RANKL via a direct binding to the 5Ј-flanking region of the RANKL. Functional characterization revealed that RANKL did not induce VSMC calcification, nor was RANKL required for oxidative stress-induced VSMC calcification. Using a coculture system, we demonstrated that VSMCexpressed RANKL induced migration as well as differentiation of bone marrow-derived macrophages into multinucleated, tartrate-resistant acid phosphatase-positive osteoclast-like cells. These effects were inhibited by the RANKL antagonist osteoprotegerin and with VSMC deficient in Runx2 or RANKL. Conclusion-We demonstrate that Runx2 directly binds to the promoter and controls the expression of RANKL, which mediates the crosstalk between calcifying VSMC and migration and differentiation of macrophages into osteoclast-like cells in the atherosclerotic lesions. Our studies provide novel mechanistic insights into the regulation and function of VSMC-derived RANKL in the pathogenesis of atherosclerosis and vascular calcification. (Arterioscler Thromb Vasc Biol. 2011;31:1387-1396.)
A therosclerosis is characterized by the formation of raised, often calcified lesions in the arterial intima, leading to narrowing of the vessel lumen. Vascular calcification reduces arterial compliance 1 and therefore represents a key factor in the hemodynamic consequences of atherosclerosis. Accumulating evidence has demonstrated that vascular calcification is a cell-regulated process with many similarities to the mechanisms of embryonic osteogenesis, not simply a passive precipitation of crystals. [2] [3] [4] Vascular calcification reflects an osteochondrogenic transformation of vascular smooth muscle cells (VSMC), which is associated with increased expression of growth factors, matrix proteins, and other bone-related markers. [5] [6] [7] 
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High levels of oxidative stress have been linked with increased prevalence of arterial calcification in hypercholes-terolemia, hypertension, diabetes mellitus, and end-stage renal disease. 8 Therefore, the generation of oxidative stress is considered to be a common final pathway by which these factors predispose to vascular calcification. Oxidative stress in atherosclerosis may lead to generation of reactive oxygen species by vascular cells, endothelial dysfunction, and plaque disruption. 9 We have previously reported that H 2 O 2 , a cellpermeable reactive oxygen species, induces VSMC calcification in vitro. 10 Receptor activator of nuclear factor-B ligand (RANKL) is a member of the tumor necrosis factor superfamily, which is the key regulator for osteoclast formation. RANKL is highly expressed in lymphoid tissues and trabecular bone, particularly in areas associated with active bone remodeling or inflammatory osteolysis. 11 In normal vessels and noncalcified arteries or valves, RANKL is frequently undetectable. By contrast, RANKL has been reported to be upregulated and expressed in calcified atherosclerotic lesions. 12 Consistently, mice that lack of osteoprotegerin (OPG), the decoy receptor for RANKL, exhibit increased vascular calcification. 13 Inhibition of RANKL by human monoclonal antibody was recently found to attenuate vascular calcium deposition in human RANKL knock-in mice. 14 These emerging studies suggest a role of RANKL in the atherosclerotic calcification. However, the molecular mechanisms underlying RANKL upregulation and its role in atherosclerotic lesions remain largely unknown. In a human osteoblast-like cell line and primary mouse bone marrow stromal cells, H 2 O 2 -or xanthine/xanthine oxidase-generated reactive oxygen species promotes the expression of RANKL. 15 Therefore, oxidative stress may contribute to the increased expression of RANKL found in calcified atherosclerotic tissues.
The present study determined the effect of oxidative stress on the expression of RANKL in VSMC and the underlying molecular mechanisms. We have previously demonstrated that the master osteogenic transcription factor Runx2 is an essential regulator for oxidative stressinduced VSMC calcification. 10 In the present study, we found that Runx2 directly binds to the promoter and induces the expression of RANKL in VSMC. Functional characterization demonstrated that RANKL does not directly induce VSMC calcification and that VSMC-expressed RANKL is not required for oxidative stress-induced VSMC calcification, although it promotes osteoclastogenesis and migration of macrophages. These findings support an important role of VSMC-expressed RANKL in regulating infiltration and differentiation of macrophages during VSMC calcification, which may shed light on the origin and formation of the osteoclast-like cells observed in calcified atherosclerotic lesions. Thus, oxidative stress may promote vascular calcification directly via Runx2, and indirectly via Runx2-upregulated RANKL, which promotes recruitment and differentiation of osteoclast-like cells in calcifying atherosclerotic lesions.
Methods
Primary mouse aortic smooth muscle cells (VSMC, passages 3 to 5) and atherogenic apolipoprotein E (ApoE) Ϫ/Ϫ mice were used for in vitro and in vivo studies. In vitro coculture was performed with VSMC and bone marrow macrophages from wild-type (WT) C57BL6 mice. Details of materials and experimental procedures are given in the Supplemental Methods section, available online at http://atvb.ahajournals.org.
Results

Runx2 and RANKL Upregulation, Macrophage Infiltration, and Tartrate-Resistant Acid Phosphatase-Positive Cells Are Associated With Vascular Calcification In ApoE ؊/؊ Mice
We have previously demonstrated that oxidative stress induces the expression of Runx2, which is essential for VSMC calcification in vitro. Using an atherosclerosis model, ApoE Ϫ/Ϫ mice, 16 we characterized the expression of Runx2 in vascular calcification in vivo. A significant increase in calcification was found in the aortic roots obtained from ApoE Ϫ/Ϫ mice fed a high-fat diet compared with those from chow-fed control animals (Pϭ0.01, Figure  1A and 1B), which was associated with high-fat dietinduced increased oxidative stress (Supplemental Figure  I) . Increases in Runx2-and RANKL-immunopositive areas were found concurrently with enhanced vascular calcification in the high-fat diet-fed animals compared with those from chow-fed mice ( Figure 1C ). Quantitative analysis confirmed significant upregulation of Runx2 and RANKL expression in the high-fat diet-fed mice (Pϭ0.01 for each, Figure 1D ).
In addition, increased macrophage infiltration was demonstrated in the aortic root of ApoE Ϫ/Ϫ mice fed the high-fat diet (Pϭ0.02, Figure 1D ), as determined by staining with a macrophage marker, CD68. 17 The area that stained positive for macrophages in the high-fat diet-fed mice was closely associated with RANKL immunopositivity ( Figure 1C ). Tartrate-resistant acid phosphatase (TRAP)-positive cells were observed in the aortic roots of high-fat diet-fed animals ( Figure 1C ), which were mainly found in the areas of highest expression of RANKL and macrophage infiltration ( Figure 1C ). The greatest expression of Runx2/RANKL and of CD68/TRAP was in the aortic sinuses at base of valve leaflets, a common site of atherosclerotic lesions. With immunofluorescent staining, we further confirmed the colocalization of Runx2 and RANKL in the calcified atherosclerotic lesions from high-fat diet-fed ApoE Ϫ/Ϫ mice ( Figure 1E ). Importantly, TRAP-positive cells were found in close apposition to the RANKL-positive areas ( Figure 1E ), supporting a link between RANKL induction and formation of osteoclast-like cells.
Oxidative Stress Induces the Expression of RANKL in VSMC During Calcification
To determine the effects of oxidative stress on the expression of RANKL in calcifying VSMC, we characterized the effects of a series of concentrations of H 2 O 2 (0.05 to 0.4 mmol/L) on RANKL expression by primary mouse VSMC. Based on quantitative real-time polymerase chain reaction (PCR), H 2 O 2 dose-dependently induced expression of RANKL in parallel with VSMC calcification (Figure 2A and 2B). Similarly, oxidative stress induced the expression of RANKL in rat and human VSMC (Supplemental Figure III) . Increased expression of RANKL protein by oxidative stress was identified predominantly in the cell lysates ( Figure 2C ), indicating that oxidative stress-induced RANKL is expressed primarily within VSMC. Furthermore, H 2 O 2 increased RANKL mRNA in a time-dependent manner, concurrently with H 2 O 2 -induced Runx2 expression ( Figure 2D ).
H 2 O 2 -Responsive Element in the RANKL Promoter
To elucidate the molecular mechanism of oxidative stressinduced expression of RANKL, we examined the H 2 O 2responsive region on the RANKL gene using a series of luciferase reporter constructs containing deletion mutants of the RANKL 5Ј-flanking region: renila luciferase (RL) (full length [FL]) (Ϫ950), RL(Ϫ700), RL(Ϫ550), RL(Ϫ400), RL(Ϫ200), RL(Ϫ150), and RL(Ϫ50). 18 H 2 O 2 induced higher promoter activities in VSMC transfected with RL(FL), RL(Ϫ700), RL(Ϫ550), and RL(Ϫ400) compared with controls ( Figure 2E ), but not in VSMC transfected with RL(Ϫ200). Therefore, the Ϫ400 to Ϫ200 bp region is essential for the H 2 O 2 -induced transcription of the RANKL gene in VSMC.
Runx2 Regulates RANKL Transcription
Sequence analyses of the Ϫ400 to Ϫ200 bp region of the RANKL promoter identified multiple binding sites for the key osteogenic transcription factor Runx2 (Runx2-1, Runx2-2, Runx2-3, and Runx2-4; Figure 3A ). We previously reported that Runx2 is essential for H 2 O 2 -induced VSMC calcification. 10 To characterize Runx2 binding domains in the RANKL promoter, a chromatin immunoprecipitation (ChIP) assay was performed using an anti-Runx2 antibody. Segments of the RANKL promoter containing the putative Runx2-binding sites were amplified by PCR using the appropriate primer sets (whole, Ϫ438/Ϫ85; R1&2, Ϫ438/Ϫ240; and R3&4, Ϫ290/Ϫ85) and DNA templates extracted from protein/DNA cross-linked samples. Runx2 was found to bind specifically to the R3&4 region (Ϫ290/Ϫ85), as well as to the entire (Ϫ438/Ϫ85) region of the RANKL promoter ( Figure  3B ). With primer sets spanning each of the putative Runx2binding regions of the RANKL promoter (R1 to R4), the Runx2 binding sites were located preferentially to the R3 region and, to a lesser extent, the R4 region ( Figure 3C ).
Furthermore, direct binding of Runx2 to the RANKL promoter was confirmed by electrophoretic mobility shift assay (EMSA) with oligonucleotides derived from putative Runx2binding sites in the RANKL promoter (P1, Ϫ378/Ϫ354; P2, Ϫ337/Ϫ313; P3, Ϫ216/Ϫ192; P4, Ϫ190/Ϫ166). The previously reported Runx2 consensus binding probe was used as a positive control. 19 As with the results of ChIP assay, binding complexes were detected predominantly with the P3 probe, and with other probes to a much lesser extent. Mutations of the Runx2 binding sites on all probes (P1m, P2m, P3m, and P4m) abolished their binding to Runx2, indicating binding specificity ( Figure 3D ). The P3 putative Runx2 binding site was found to be conserved among the mouse, rat and human RANKL gene, but the P1, P2, and P4 sites were not (Supplemental Figure IV) . Runx2 binding to the P3 probe was blocked by excess amounts of cold P3 probe and Runx2 consensus probe but not by P3 probe with a mutation in Runx2 binding site (P3m) ( Figure 3E ). Moreover, antibody specific for Runx2 produced a supershift of the Runx2 binding complex, confirming the specificity of Runx2 in the DNAprotein complex ( Figure 3F ). In addition, mutation of P3 inhibited H 2 O 2 -and Runx2-induced luciferase activity driven by RANKL promoter (Supplemental Figure IV) . Taken together, these results indicate a specific and predominant binding of Runx2 to the P3 region of RANKL promoter.
Runx2 Is Essential for Oxidative Stress-Induced RANKL Expression and Sufficient to Induce RANKL
To determine whether Runx2 is required for oxidative stressinduced expression of RANKL, we used lentivirus-mediated short hairpin RNA (shRNA) to knock down the expression of Runx2 in VSMC. 10 As expected, H 2 O 2 -induced Runx2 expression in VSMC was not affected by control virus (lenti-green fluorescent protein); however, Runx2 expression was inhibited in VSMC infected with shRNA against Runx2 ( Figure 3G ). The inhibitory effect of lentiviral shRNA on Runx2 expression resulted in blockage of H 2 O 2 -induced RANKL expression in VSMC ( Figure 3H ), confirming that Runx2 is essential for H 2 O 2 -induced expression of RANKL in VSMC. In addition, adenovirus-mediated overexpression of Runx2 alone was sufficient to induce the expression of RANKL in VSMC ( Figure 3I ), which is consistent with our previous finding that overexpression of Runx2 induces VSMC calcification. 10 Therefore, increased expression of Runx2, either induced by H 2 O 2 or mediated by viral infection, upregulates the expression of RANKL in calcifying VSMC.
RANKL Does Not Induce VSMC Calcification and Is Not Required for Oxidative Stress-Induced VSMC Calcification
To assess whether RANKL directly induces VSMC calcification, recombinant RANKL protein (100 ng/mL) was added to VSMC in osteogenic media with or without 0.4 mmol/L H 2 O 2 . As expected, H 2 O 2 induced calcification of VSMC ( Figure 4A ), whereas RANKL did not ( Figure 4A and 4B). OPG (50 ng/mL), a soluble decoy receptor of RANKL, did not block calcification induced by oxidative stress ( Figure 4A ). In addition, H 2 O 2 -induced calcification was not inhibited in VSMC from RANKL-deficient mice compared with WT VSMC, as determined by von Kossa cytochemical staining, as well as by quantification of calcium levels in cell lysates ( Figure 4C and 4D) , indicating that RANKL signaling is not essential for oxidative stress-induced VSMC calcification.
Oxidative Stress-Stimulated VSMC Promote Migration of Bone Marrow Macrophages in a Runx2/RANKL-Dependent Manner
Soluble RANKL protein has been shown to exhibit chemotactic properties toward human monocytes. 20 To test whether RANKL expression by VSMC may affect bone marrow macrophage (BMM) migration, freshly isolated mouse BMM were indirectly exposed to VSMC using the Transwell migration assay. Soluble RANKL protein at 100 ng/mL was used as a positive control. As shown in Figure  5A , oxidative stress-stimulated VSMC increased the migration of BMM by 5.2-fold compared with serum free control, whereas unstimulated VSMC had no effect on BMM migration. The effects of oxidative stress-stimulated VSMC on BMM migration was blocked in VSMC from RANKL-deficient mice or in VSMC with Runx2 knockdown, demonstrating the requirement of Runx2regulated RANKL production by VSMC. Furthermore, addition of OPG abolished the effect of oxidative stressstimulated VSMC on BMM migration ( Figure 5B) , supporting a role of RANKL expressed by VSMC in regulating BMM migration.
Oxidative Stress-Stimulated VSMC Promote Osteoclastic Differentiation of Macrophages in a Runx2/RANKL-Dependent Manner
RANKL is a central regulator of osteoclast formation, and RANKL produced by osteoblasts induces osteoclastic differentiation of osteoclast precursors. 11 The presence of TRAPpositive osteoclast-like cells in areas of high RANKL expression prompted us to test the hypothesis that oxidative stress-induced RANKL in VSMC during calcification may induce osteoclast formation. With the use of a coculture system of VSMC and BMM as a source of osteoclast precursors, we determined that H 2 O 2 -stimulated VSMC induced the formation of multinucleated TRAP-positive cells from BMM, compared with unstimulated VSMC ( Figure 6A ). However, in VSMC from RANKL-deficient mice, H 2 O 2 treatment did not induce any multinucleated TRAP-positive cells in coculture with BMM ( Figure 6A) , indicating a direct effect of VSMC-derived RANKL. Furthermore, osteoclastic differentiation was restored by addition of soluble RANKL (100 ng/mL) to the coculture of RANKL Ϫ/Ϫ VSMC with BMM ( Figure 6A ). Addition of OPG, however, completely blocked the stimulatory effects obtained with H 2 O 2 ( Figure 6B ). Furthermore, VSMC with Runx2 knockdown by lentiviral shRNA failed to promote the formation of multinucleated TRAP-positive cells in a coculture system when compared with WT VSMC (Figure 6C ), confirming that Runx2 is essential for oxidative stress-induced RANKL expression in VSMC and that it functions in regulating osteoclastic differentiation.
Discussion
Using atherogenic ApoE Ϫ/Ϫ mice, we determined that increased Runx2 and RANKL were colocalized in the calcified atherosclerotic lesions, in close apposition to TRAP-positive osteoclast-like cells. We demonstrated for the first time that oxidative stress enhanced expression of RANKL in primary murine VSMC, which was mediated by the osteogenic transcription factor Runx2 via a direct binding to the RANKL promoter. VSMC-derived RANKL was not essential for oxidative stress induced VSMC calcification, and RANKL did not induce VSMC calcification when added to the culture media. Instead, VSMC-derived RANKL was found to promote migration and osteoclastic differentiation of BMM. These observations provide novel evidence for the molecular mechanism underlying RANKL upregulation in atherosclerotic calcification and the function of Runx2/RANKL in regulating the crosstalk between calcifying VSMC and macrophages in the genesis of TRAP-positive osteoclast-like cells in atherosclerotic lesions. Increased expression of RANKL was found to colocalize with Runx2 in the calcified atherosclerotic lesions (Figure 1) . Such an observation is consistent with previous reports that RANKL expression is increased in calcified atherosclerotic lesions but not in normal vessels, 12 and mice deficient in OPG develop arterial calcifications. 13 RANKL is a transmembrane protein expressed in the bone marrow microenvironment and stimulates osteoclast progenitor cells to differentiate into osteoclasts. 21 Under normal steady-state conditions in adults, mineral deposition by osteoblasts and mineral resorption by osteoclasts are delicately balanced to maintain bone homeostasis. 22 Similar to the observation in human atherosclerotic arteries, 23 we identified TRAP-positive multinucleated osteoclast-like cells in close apposition to the calcified areas. The high levels of RANKL and the presence of TRAPpositive osteoclast-like cells in calcified atherosclerotic lesions support the notion that molecular mechanisms similar to bone remodeling processes are manifested within mineralized atherosclerotic artery walls. 22 Increased oxidative stress in the atherosclerotic lesions may contribute to the increase in RANKL expression. Oxi-dative stress induced expression of RANKL in mouse, rat and human VSMC (Figure 2 and Supplemental Figure III) , suggesting a common regulatory mechanism. These results are consistent with a previous report that reactive oxygen species induce RANKL expression in bone marrow stromal cells in vitro. 15 Similarly, RANKL expression is increased during bone morphogenetic protein-2-and calcitriol-induced vascular calcification. 24 -26 The molecular mechanism underlying H 2 O 2 -induced expression of RANKL in VSMC is mediated by Runx2 via a direct binding to the RANKL promoter (Figures 2 and 3 ). Runx2 is a transcription factor that belongs to the runt-domain gene family and is essential for osteoblast differentiation and gene expression of bone matrix proteins. 27 We previously demonstrated that oxidative stress induces VSMC calcification in vitro via Runx2dependent signals. 10 Runx2 was found to be essential for the Figure 5 . Oxidative stress-stimulated VSMC promote BMM migration in a Runx2/RANKL-dependent manner. A, After VSMC were cultured in osteogenic media for 2 weeks with or without 0.4 mmol/L H 2 O 2 , cells were coated on the lower side of a Transwell filter, and DiI (Invitrogen)-labeled BMM were added to the upper chambers. After 24 hours, migrated BMM were measured using a microplate fluorescence reader. Results from 3 independent experiments performed in duplicate are shown (Pϭnot significant for unstimulated WT VSMC vs serum-free, Pϭ0.01 for oxidative stress-stimulated WT VSMC vs serumfree). B, WT VSMC were preincubated in osteogenic media for 2 weeks with or without 0.4 mmol/L H 2 O 2 and then coated on the lower side of Transwell. Effects of conditioned media from the preincubation or addition of OPG (50 ng/mL) on macrophage migration was determined. Results from 3 independent experiments performed in duplicate are shown (*Pϭ0.005 for oxidative stress-stimulated VSMC vs serum-free control).
Figure 6.
Oxidative stress-stimulated VSMC promote osteoclastic differentiation of BMM in a Runx2/RANKL-dependent manner. BMM were plated on top of VSMC that were preincubated in osteogenic media for 2 weeks with or without 0.4 mmol/L H 2 O 2 ; cultured in ␣-minimum essential medium containing 10% Hi-FBS/10 ng/mL macrophage colony-stimulating factor with or without RANKL (100 ng/mL); and stained for TRAP 1 week later. A, Representative images of stained dishes (left) and microscopic views (ϫ100, right) from 4 independent experiments performed in duplicate. B, Effect of OPG (500 ng/mL) on the coculture. Representative images of TRAP stained dishes (top row) and microscopic views (ϫ100, bottom row) from 2 independent experiments performed in duplicate are shown. C, Runx2 knockout VSMC were cocultured with BMM for 1 week. Representative images of TRAP stained dishes (left) and microscopic views (ϫ100, right) from 3 independent experiments performed in duplicate are shown. expression of RANKL ( Figure 3H ) and sufficient to induce RANKL in VSMC ( Figure 3I ), findings that are consistent with the inhibition of RANKL expression in Runx2-deficient osteoblast cells. 28 By contrast, calcitriol-induced RANKL expression was not affected in Runx2-deficient calvarial cells. 29 In the ST2 mouse bone marrow stromal cells, decreased Runx2 expression by protein kinase A activation was associated with increased RANKL expression. 30 Accordingly, the effects of Runx2 on RANKL expression appear to differ among cell types and their response to different stimuli.
The Runx2 binding domains were identified within Ϫ400 to Ϫ200bp in the RANKL promoter in VSMC, with a predominant binding of Runx2 to the Ϫ206 to Ϫ201 bp region (P3, Figure 3) , which is the most conserved sequence among human, rat, and mouse RANKL gene (Supplemental Figure IV) . Mutation of P3 was found to inhibit Runx2 binding ( Figure 3E and 3F) , as well as H 2 O 2 -induced and Runx2-induced luciferase activity of the RANKL promoter (Supplemental Figure IV) . Similar to our finding, deletion or mutation of Runx2 binding sites within the RANKL promoter or overexpression of a dominant negative Runx2 abolished bone morphogenetic protein-2-and Smad1-mediated activation of RANKL promoter activity in chondrocytes. 31 Despite structural similarity to the core Runx2-binding sequences (5Ј-ACCPuCPu-3Ј), the other putative Runx2 binding site showed significantly less binding activity, suggesting the importance of overall genomic context containing the core sequences for Runx2 activity. In the ST2 bone marrow stromal cells, mutation of each of the 3 putative Runx2 binding sites on the RANKL promoter (corresponding to P1, P3, and P4 in the present study), especially the P3 and P4 sites, decreased the basal promoter activity of RANKL and inhibited protein kinase A-induced RANKL expression. 30 Therefore, our study is consistent with the study in ST2 cells with respect to supporting the requirement for direct binding of Runx2 on the RANKL promoter, especially the P3 region, in regulating RANKL expression.
Unlike previous reports that RANKL promotes an osteogenic phenotype in aortic myofibroblast 32 and rat aortic VSMC calcification, 33 we did not find a direct effect of RANKL on mouse VSMC calcification ( Figure 4A ), excluding the possibility of autocrine or paracrine effects of VSMCderived RANKL on calcification. Similar results were also found in calcifying vascular cells (CVC); treatment of RANKL (100 ng/mL) in osteogenic media did not induce calcification of these cells (Supplemental Figure II) . Differences in model cell systems may explain the differences between the present results and prior reports. 32, 33 The difference in expression of RANK, the receptor for RANKL, in mouse and rat VSMC was not statistically significant, which may not contribute to the different effects of RANKL on the calcification of mouse and rat VSMC (Supplemental Figure  V) . In addition, patterns of mineral deposition seen by von Kossa staining are more diffuse in rat cells and more nodular in mouse cells, 33 suggesting that RANKL induction of calcium positive stains in rat aortic VSMC may occur via a distinct mechanism of biomineralization or via increased intracellular calcium. In any case, oxidative stress promoted calcification in RANKL-deficient VSMC, supporting the concept that VSMC-derived RANKL is not essential for direct regulation of VSMC calcification in vitro ( Figure 4B ).
We found that in VSMC, the majority of RANKL protein induced by oxidative stress was cell-associated ( Figure 2C) , unlike in activated murine T lymphocytes, which secrete an active soluble form of RANKL into the culture medium. 34 In MC3T3-E1 cells, mechanical strain has been shown to increase membrane-bound RANKL at the expense of soluble RANKL, via a reduction in ectodomain shedding. 35 The dominance of VSMC-associated RANKL over soluble RANKL in the context of oxidative stress may explain why the RANKL protein is concentrated in areas of atherosclerosis, whereas serum levels of soluble RANKL are inversely correlated with presence of coronary artery disease. 36 VSMC exposed to oxidative stress induced the migration of BMM in a Runx2/RANKL-dependent manner, supporting the role of oxidative stress-induced RANKL from VSMC in regulating macrophage infiltration ( Figure 5 ). Macrophage infiltration plays a significant role in the formation of atherosclerotic lesions. 37 Aikawa et al found that macrophage infiltration and inflammation precede the osteogenic conversion of VSMC. 38 Deficiency of OPG in ApoE Ϫ/Ϫ mice accelerates atherosclerotic lesion progression and increases atherosclerotic calcification and macrophage infiltration, suggesting a role of RANKL in upregulating calcification and macrophage infiltration in vivo. 21 Consistently, we demonstrated increased macrophage infiltration in close association with Runx2/RANKL expression in calcified vessel walls ( Figure 1C and 1E ). RANKL has been reported to induce migration of MonoMac-6 monocytic cells, as well as peripheral blood mononuclear cells, in a dose-dependent manner with an potency similar to that of monocyte chemoattractant protein-1, 20 a chemotactic factor that contributes to atherogenesis. 39 The effect of RANKL on macrophage recruitment may be attributed to its induction of several cytokines, including CCL22 (macrophage-derived chemokine), monocyte chemoattractant protein-1, and interleukin-8. 40 -42 The chemokines, in turn, increase RANKL expression, 43 amplifying the inflammatory process. 44, 45 In addition, RANKL has been found to upregulate RANK expression on monocytes, to promote cell survival, and activate the capacity of monocytes for antigen presentation through induction of costimulatory molecules. 46, 47 In bone, RANKL expression by osteoblastic and/stromal cells is essential for the complete development of multinucleated bone-resorptive osteoclasts from monocytic precursors, 11 and for the resorptive activity and survival of mature osteoclasts as well. 48 Consistently, we found that VSMCderived RANKL induced the differentiation of BMM into multinucleated TRAP-positive cells, an effect that was antagonized by exogenous OPG (Figure 6 ). These results are consistent with the observation by Collin-Osdoby et al that tumor necrosis factor-␣-activated human microvascular endothelial cells, which express RANKL on the cell surface, promote osteoclastogenesis in cocultures with human monocyte precursors via a RANKL-mediated mechanism. 49 In contrast, calcifying vascular cells and conditioned media from calcifying vascular cells were previously shown to inhibit osteoclastic differentiation in a coculture system 50 ; however, calcifying vascular cells expression of RANKL expression during osteoblastic differentiation and mineralization was not determined. 50 The role of osteoclasts in atherosclerotic calcification is still not clear. In keeping with the hypothesis that the process of vascular calcification resembles that observed in bone tissue, net calcium deposition in vessel walls might result from focal perturbation of the balance between osteoblast-like cells and osteoclast-like cells. 22 Thus, our observations support the notion that osteoclast-like cells in the vascular wall may represent important cellular mediators of mineral resorption in arteries. Nevertheless, our observation that oxidative stress promotes VSMC induction of osteoclastogenesis may shed light on the origin and potential role of osteoclast-like cells in atherosclerotic plaque. Additional studies are warranted to characterize the pathological function of osteoclast-like cells in the regulation of vascular calcification.
Taken together, our studies demonstrate the molecular mechanisms underlying Runx2-regulated expression of RANKL and its function during oxidative stress-induced VSMC calcification. The results indicate that expression of Runx2 and RANKL and vascular calcification are associated with macrophage infiltration and TRAP-positive cells in atherosclerotic lesions of ApoE Ϫ/Ϫ mice; that VSMC-derived RANKL, induced by Runx2-dependent signaling, increases migration and osteoclastic differentiation of macrophages; that RANKL does not directly regulate osteogenic differentiation of VSMC; and that osteoclast-like cells arise in the proximity to mineralized areas of atherosclerotic lesions, making it likely that osteoclastic cells indirectly regulate vascular calcification, as seen in the interplay of osteoblasts and osteoclasts in regulating bone homeostasis.
